CliffBio
small molecule

GEMCITABINE HYDROCHLORIDE

GEMCITABINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyShilpa Medicare →See this company's full patent-cliff portfolio

Drug detail

Brand nameGEMCITABINE HYDROCHLORIDE
Active ingredientGEMCITABINE HYDROCHLORIDE
StrengthEQ 1GM BASE/VIAL
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
FDA approvalFebruary 2019
Marketing statusRX

More from Shilpa Medicare

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

GEMCITABINE HYDROCHLORIDE patent cliff — loss of exclusivity — | CliffBio